Grufity logoGrufity logo

Masimo Corp Stock Research

MASI

175.16USD+2.02(+1.17%)Delayed

Market Summary

USD175.16+2.02
Delayed
1.17%

MASI Alerts

MASI Stock Price

MASI RSI Chart

MASI Valuation

Market Cap

9.2B

Price/Earnings (Trailing)

53.83

Price/Sales (Trailing)

4.52

EV/EBITDA

27.27

Price/Free Cashflow

-392.99

MASI Price/Sales (Trailing)

MASI Profitability

EBT Margin

9.50%

Return on Equity

12.76%

Return on Assets

5.32%

Free Cashflow Yield

-0.25%

MASI Fundamentals

MASI Revenue

Revenue (TTM)

2.0B

Revenue Y/Y

88.35%

Revenue Q/Q

12.32%

MASI Earnings

Earnings (TTM)

170.8M

Earnings Y/Y

-34.43%

Earnings Q/Q

109.39%

Price Action

52 Week Range

108.89184.97
(Low)(High)

Last 7 days

-1.5%

Last 30 days

4.7%

Last 90 days

20.0%

Trailing 12 Months

24.8%

MASI Financial Health

Current Ratio

2.08

Debt/Equity

0.78

Debt/Cashflow

0.22

MASI Investor Care

Buy Backs (1Y)

5.06%

Diluted EPS (TTM)

2.6

Peers (Alternatives to Masimo)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
105.5B
30.8B
-7.09% -24.59%
25.94
3.43
-3.19% -17.38%
84.2B
6.2B
-4.47% -13.27%
63.66
13.53
8.97% -22.43%
49.8B
5.4B
2.41% -25.12%
32.74
9.26
2.86% 1.25%
25.2B
3.7B
-2.18% -18.57%
69.75
6.75
-5.51% -53.17%
19.4B
4.5B
-6.15% 10.39%
19.57
4.34
-18.71% -42.28%
MID-CAP
10.2B
847.1M
-3.64% 34.52%
-5.1K
12.05
13.32% -137.89%
6.3B
2.6B
-5.67% -16.73%
25.77
2.44
2.40% -18.20%
2.8B
1.0B
-8.51% -34.72%
-34.66
2.67
3.45% -228.84%
2.4B
93.5M
9.82% 320.78%
-67.51
26.17
208.83% 18.06%
2.3B
1.0B
-24.45% -43.12%
-26.13
2.21
-1.31% 36.50%
SMALL-CAP
1.7B
161.7M
-0.60% 21.99%
-22.89
10.65
27.64% -82.82%
1.3B
820.0M
-8.35% -12.22%
25.89
1.59
10.13% 701.59%
853.3M
154.8M
-6.04% 0.61%
-8.2
5.51
60.29% -2309.58%
307.0M
377.2M
-43.75% -56.70%
-3.66
0.81
5.37% -1222.79%
50.9M
470.7M
-28.69% -81.07%
-0.59
0.11
-26.17% 15.66%

Financials for Masimo

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue16.6%2,0361,7461,5051,2441,239
Gross Profit10.3%1,059960881816808
Operating Expenses13.7%849746655546533
  S&GA Expenses14.2%657576502407395
  R&D Expenses12.4%191170153139137
EBITDA17.6%330280328305-
EBITDA Margin0.9%0.16*0.16*0.22*0.25*-
Earnings Before Taxes-9.8%193214230269274
EBT Margin-22.6%0.10*0.12*0.15*0.22*-
Net Income-10.4%171191223230-
Net Income Margin-14.2%0.08*0.10*0.13*0.18*-
Free Cahsflow-125.2%-23.4093.00164192-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets5.0%3,2113,0562,9611,9091,887
  Current Assets5.1%1,3091,2461,1581,2251,239
    Cash Equivalents-4.5%210220218720745
  Inventory1.1%501495449213201
  Net PPE8.1%403372371300273
  Goodwill-0.2%445446435352100
Liabilities3.8%1,8721,8041,758327337
  Current Liabilities7.3%630587552254268
    LT Debt, Non Current-1.0%942951922--
Shareholder's Equity6.9%1,3391,2531,2031,5821,550
  Retained Earnings2.4%1,7141,6741,6361,6171,571
  Additional Paid-In Capital0.9%782775759741753
Accumulated Depreciation-158----
Shares Outstanding-0.2%53.0053.0053.0056.0055.00
Cashflow (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations-78.0%29.00134205229265
  Share Based Compensation-9.7%48.0053.0052.0043.0045.00
Cashflow From Investing-1.6%-1,057-1,040-1,047-50.84-37.53
Cashflow From Financing-1.7%520529510-4.78-122
  Buy Backs0.0%4024014010.00129

Risks for MASI

What is the probability of a big loss on MASI?

41.1%


Probability that Masimo stock will be more than 20% underwater in next one year

20.8%


Probability that Masimo stock will be more than 30% underwater in next one year.

19.6%


Probability that Masimo stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does MASI drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Masimo was unfortunately bought at previous high price.

Drawdowns

Returns for MASI

Cumulative Returns on MASI

24.2%


10-Year Cumulative Returns

23.7%


7-Year Cumulative Returns

14.8%


5-Year Cumulative Returns

-2.5%


3-Year Cumulative Returns

What are the long-term rolling returns for MASI?

FIve years rolling returns for Masimo.

Annualized Returns

Which funds bought or sold MASI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
reduced
-7.92
-54,067
1,487,930
-%
2023-03-10
BAILLIE GIFFORD & CO
added
2.67
1,006,170
14,223,200
0.01%
2023-03-06
Rockefeller Capital Management L.P.
reduced
-91.4
-17,750,000
1,758,000
0.01%
2023-03-06
NORTH STAR ASSET MANAGEMENT INC
reduced
-25.57
-245,314
870,686
0.05%
2023-02-28
Voya Investment Management LLC
reduced
-0.39
120,654
2,857,650
-%
2023-02-24
NATIXIS
new
-
148
148
-%
2023-02-24
National Pension Service
unchanged
-
56.00
1,480
-%
2023-02-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
unchanged
-
52,000
1,145,000
0.01%
2023-02-22
CVA Family Office, LLC
sold off
-100
-3,000
-
-%
2023-02-21
Blue Whale Capital LLP
sold off
-100
-734,000
-
-%

1–10 of 46

Latest Funds Activity

Are funds buying MASI calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own MASI
No. of Funds

Masimo News

Nasdaq

Masimo (MASI) Moves to Strong Buy: Rationale Behind the Upgrade.

Nasdaq,
3 days ago

Nasdaq

Zacks Investment Research

Investor's Business Daily

Schedule 13G FIlings of Masimo

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Mar 13, 2023
politan capital management lp
9.0%
4,739,963
SC 13D/A
Mar 06, 2023
politan capital management lp
9.0%
4,739,963
SC 13D/A
Feb 14, 2023
kiani joe e
9.3%
4,975,021
SC 13G/A
Feb 09, 2023
vanguard group inc
9.24%
4,855,501
SC 13G/A
Jan 26, 2023
blackrock inc.
11.3%
5,956,832
SC 13G/A
Jan 20, 2023
blackrock inc.
11.3%
5,956,832
SC 13G/A
Jan 10, 2023
fmr llc
-
0
SC 13G
Oct 21, 2022
politan capital management lp
8.8%
4,648,869
SC 13D/A
Sep 27, 2022
politan capital management lp
8.8%
4,648,869
SC 13D/A
Aug 16, 2022
politan capital management lp
8.4%
4,431,284
SC 13D

MASI Fair Value

Masimo fair value in different scenarios

The table shows the Fair Value estimates for Masimo for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

130.76

-25.35%

166.51

-4.94%

245.79

40.32%

317.36

81.18%

391.05

123.25%
Current Inflation

119.88

-31.56%

150.39

-14.14%

217.63

24.25%

277.36

58.35%

338.92

93.49%
Very High Inflation

106.47

-39.22%

130.91

-25.26%

184.42

5.29%

230.92

31.83%

278.96

59.26%

Historical Masimo Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Masimo

View All Filings
Date Filed Form Type Document
Mar 13, 2023
SC 13D/A
13D - Major Acquisition
Mar 07, 2023
4
Insider Trading
Mar 07, 2023
4
Insider Trading
Mar 07, 2023
4
Insider Trading
Mar 07, 2023
4
Insider Trading
Mar 07, 2023
4
Insider Trading
Mar 07, 2023
4
Insider Trading
Mar 06, 2023
SC 13D/A
13D - Major Acquisition
Mar 01, 2023
10-K
Annual Report
Feb 28, 2023
3
Insider Trading

Latest Insider Trading transactions for MASI

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-03
Levy Tao
acquired
-
-
5,016
evp, bus dev
2023-03-03
McClenahan Thomas Samuel
sold (taxes)
-486,723
182
-2,668
evp, gen counsel & corp sec
2023-03-03
McClenahan Thomas Samuel
acquired
-
-
5,016
evp, gen counsel & corp sec
2023-03-03
Levy Tao
sold (taxes)
-487,453
182
-2,672
evp, bus dev
2023-03-03
KIANI JOE E
acquired
-
-
50,161
ceo and chairman of the board
2023-03-03
Young Micah W
acquired
-
-
5,016
evp & chief financial officer
2023-03-03
Young Micah W
sold (taxes)
-485,811
182
-2,663
evp & chief financial officer
2023-03-03
KIANI JOE E
sold (taxes)
-4,817,980
182
-26,410
ceo and chairman of the board
2023-03-03
Muhsin Bilal
sold (taxes)
-967,244
182
-5,302
chief operating officer
2023-03-03
Muhsin Bilal
acquired
-
-
10,032
chief operating officer

1–10 of 50

Joe E. Kiani
6200
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.

MASI Income Statement

2022-12-31
CONSOLIDATED STATEMENTS OF OPERATIONS CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Income Statement [Abstract]   
Revenue$ 2,035.8$ 1,239.2$ 1,143.7
Cost of goods sold977.0430.8400.7
Gross profit1,058.8808.4743.0
Selling, general and administrative657.4395.4369.0
Research and development191.4137.2118.7
Litigation awards, settlements/or defense costs0.00.0(0.5)
Total operating expenses848.8532.6487.2
Operating income210.0275.8255.8
Non-operating (loss) income(16.6)(1.4)7.9
Income before provision for income taxes193.4274.4263.7
Provision for income taxes49.944.823.4
Net income$ 143.5$ 229.6$ 240.3
Net income per share:   
Basic (in dollars per share)$ 2.68$ 4.16$ 4.39
Diluted (in dollars per share)$ 2.60$ 3.98$ 4.14
Weighted-average shares used in per share calculations:   
Basic (in shares)53.655.254.7
Diluted (in shares)55.257.758.0

MASI Balance Sheet

2022-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2022
Jan. 01, 2022
Current assets  
Cash and cash equivalents$ 202.9$ 745.3
Trade accounts receivable, net of allowance for credit losses of $7.7 and $2.2 at December 31, 2022 and January 1, 2022, respectively445.9200.8
Inventories501.0201.4
Other current assets158.891.0
Total current assets1,308.61,238.5
Lease receivable, non-current73.173.6
Deferred costs and other contract assets41.928.1
Property and equipment, net402.5272.8
Finite-lived intangible assets, net460.672.5
Trademarks - (Note 9)262.00.0
Goodwill445.4100.3
Deferred tax assets102.552.6
Other non-current assets114.048.6
Total assets3,210.61,887.0
Current liabilities  
Accounts payable276.875.6
Accrued compensation89.370.8
Deferred revenue and other contract-related liabilities, current80.650.9
Other current liabilities183.370.4
Total current liabilities630.0267.7
Long-term debt941.60.0
Deferred tax liabilities163.65.1
Other non-current liabilities136.564.0
Total liabilities1,871.7336.8
Commitments and contingencies - (Note 24)
Stockholders’ equity  
Preferred stock, $0.001 par value; 5.0 shares authorized; 0.0 shares issued and outstanding0.00.0
Common stock, $0.001 par value; 100.0 shares authorized; 52.5 and 55.3 shares issued and outstanding at December 31, 2022 and January 1, 2022, respectively0.10.1
Treasury stock, 19.5 and 16.5 shares at December 31, 2022 and January 1, 2022, respectively(1,169.2)(767.7)
Additional paid-in capital782.2752.5
Accumulated other comprehensive income (loss)11.5(5.5)
Retained earnings1,714.31,570.8
Total stockholders’ equity1,338.91,550.2
Total liabilities and stockholders’ equity3,210.61,887.0
Customer relationships  
Current assets  
Finite-lived intangible assets, net201.615.3
Acquired technologies  
Current assets  
Finite-lived intangible assets, net160.119.7
Other intangible assets, net  
Current assets  
Finite-lived intangible assets, net$ 98.9$ 37.5